Digital pathology is the process of digitizing glass slides using a whole slide image scanner and then analyzing the digital images using an image viewer, typically on a computer monitor or mobile device. Digital pathology offers a better viewing experience, which enhances analysis. This lowers diagnostic error rates. These tools additionally provide service providers immediate access to earlier cases for comparison. These advanced systems store data for use in long-term predictive analysis. Specimens are barcoded to reduce the chance of misidentification. Also, this removes concerns about lost data due to slide breakage. In the modern world, digital pathology has many benefits including improved disease diagnosis accuracy, quicker recovery times, increased pathologist productivity, and so on. As a result of these benefits, healthcare facilities are increasingly using digital pathology platforms for disease diagnosis, and major market players are getting involved in product launch process.
Market Dynamics
The use of new technologies for the development of innovative digital pathology platform is expected to drive the growth of the global digital pathology market over the forecast period. For instance, in June 2022, Tribun Health, a software company, launched TeleSlide Patho 5, an online telepathology platform which is utilized for sharing digital pathology slides and other multimedia documents.
Increasing number of partnerships by the market players is expected to drive the market growth over forecast period. For instance, on September 23, 2022, Paige AI, Inc., a provider of digital pathology solutions and clinical AI applications, and OptraScan, a producer of whole slide scanners, announced a partnership to streamline the adoption of digital pathology technology in the U.S., European Union countries, and U.K. The companies’ goal is to lower obstacles to glass pathology slide digitization, which will improve oncology and pathology workflows.
Key features of the study
- This report will provide in-depth analysis of the Global Digital Pathology Market , and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It will elucidate potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the Global Digital Pathology Market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, Propath UK Limited, Inspirata, Inc., Hamamatsu Photonics, Inc., OracleBio Limited, MD Biosciences, Aiforia, Xybion Digital Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The Global Digital Pathology Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Digital Pathology Market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2025 - 2032)
- Image Analysis Software
- Scanner
- Services
- Therapeutic Area Insights (Revenue, USD Mn, 2025 - 2032)
- Oncology
- Hematology
- Autoimmune Disorders
- Dermatology
- Others
- Technology Type Insights (Revenue, USD Mn, 2025 - 2032)
- Immunohistochemistry
- ISH & FISH
- Immunofluorescence
- Others
- Industry Insights (Revenue, USD Mn, 2025 - 2032)
- Pharmaceutical and Biotechnology Companies
- Diagnostic Labs
- Hospital Laboratories
- Others
- Regional Insights (Revenue, USD Mn, 2025 - 2032)
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Leica Biosystems Nussloch GmbH
- Olympus Corporation
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- GE Healthcare
- Mikroscan Technologies, Inc.
- Koninklijke Philips N.V.
- Sectra AB
- Propath UK Limited
- Inspirata, Inc.
- Hamamatsu Photonics, Inc.
- OracleBio Limited
- MD Biosciences
- Aiforia
- Xybion Digital Inc.
- Nucleai, Inc.
